NEW YORK

,

April 9, 2021

/PRNewswire/ —

If you own shares in any of the companies listed above and

would like to discuss our investigations or have any questions concerning

this notice or your rights or interests, please contact:

Joshua Rubin, Esq.



WeissLaw LLP

1500 Broadway, 16

^th

Floor


New York

, NY  10036


(212) 682-3025



(888) 593-4771



[email protected]

FLIR Systems, Inc.


(NASDAQ: FLIR)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

FLIR Systems, Inc. (NASDAQ: FLIR)

in connection with the proposed acquisition of the company by Teledyne Technologies Incorporated (“Teledyne”).  Under the terms of the merger agreement, FLIR shareholders will receive

$28.00

in cash and 0.0718 shares of Teledyne common stock for each FLIR share that they own, representing implied per-share merger consideration of

$58.10

based upon Teledyne’s

April 8, 2021

closing price of

$419.10

.  If you own FLIR shares and wish to discuss this investigation or your rights, please call or visit our website:

https://www.weisslawllp.com/flir

Newtown Lane Marketing, Inc. (OTC: NTWN)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

Newtown Lane Marketing, Inc. (OTC: NTWN)

in connection with the company’s proposed merger with Appgate.  Under the terms of the merger agreement, NTWN will acquire Appgate through a reverse merger that will result in Appgate becoming a publicly traded company.  If you own NTWN shares and wish to discuss this investigation or your rights, please call or visit our website:

https://weisslawllp.com/news/ntwn/

Obalon Therapeutics, Inc. (NASDAQ: OBLN)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of

Obalon Therapeutics, Inc. (NASDAQ: OBLN)

in connection with the proposed merger of the company with ReShape Lifesciences Inc. (“ReShape”).  Under the terms of the merger agreement, ReShape will acquire OBLN in an all-stock transaction, pursuant to which OBLN will be renamed ReShape Lifesciences Inc.  If you own OBLN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:

https://www.weisslawllp.com/obln/

Glu Mobile Inc. (NASDAQ: GLUU)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Glu Mobile Inc. (NASDAQ: GLUU) in connection with the proposed acquisition of the company by Electronic Arts Inc.  Under the terms of the agreement, the Company’s shareholders will receive

$12.50

in cash for each share of GLUU common stock that they hold.  If you own GLUU shares and wish to discuss this investigation or your rights, please call or visit our website:

http://weisslawllp.com/gluu/

View original content to download multimedia:

http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-flir-ntwn-obln-and-gluu-shareholders-about-its-ongoing-investigations-301265983.html

SOURCE WeissLaw LLP